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Tackground: Bicuspid aortic valve is the most common congenital anomaly, oc-
urring in 1% to 2% of the population. It is the most common reason for aortic valve
eplacement, and such individuals are at significantly increased risk of aortic
omplications. Despite the clinical significance of bicuspid aortic valve, its genetic
asis remains unclear. The homeobox gene NKX2-5 occupies a central position in
he hierarchy of cardiac determinants, and mutations in this gene are associated with
icuspid aortic valve in mice. We therefore investigated the presence of mutations
n NKX2-5 among patients with bicuspid aortic valve and associated aneurysm.
ethods: Germline DNA was extracted from peripheral blood leukocytes and
omatic DNA from diseased aortic tissues of 19 patients with bicuspid aortic valve
nd associated aortic aneurysm. Three patients with trileaflet aortic valve and
neurysm served as control subjects. The entire NKX2-5 coding sequence, including
ntron-exon boundaries, was screened for mutation by means of polymerase chain
eaction, followed by DNA sequencing.
esults: Direct sequencing revealed a change in somatic (aortic) DNA 239A¡G,
eading to synonymous amino acid alteration of Glu21Glu in one patient with
icuspid aortic valve and 1 control subject. There were no other alterations detected
n the coding regions of germline or somatic genes. A known polymorphic change
n the 3= untranslated region adjacent to exon 2 was detected in both bicuspid aortic
alve and control samples. Discrepancies between germline and somatic DNA
equences were observed.
onclusion: Our study fails to demonstrate an association between bicuspid aortic
alve and NKX2-5 mutation, as has been seen in mice. Our findings support the
mportance of sequencing somatic, as well as germline, DNA.
iscuspid aortic valve (BAV) is the most common congenital valve abnor-
mality, with a prevalence of 1% to 2% in the general population.1,2 Al-
though BAV can be functionally normal, it accounts for a substantial disease
urden with particular surgical relevance. Most of these individuals will come to
urgical aortic valve replacement, whether early or late in life; conversely, approx-
mately 50% of patients coming to aortic valve replacement have BAV.3–5 More
ecently, attention has been drawn to the association of BAV with ascending aortic
ilatation and dissection. Although ascending aortic aneurysms and dissection occur
n the absence of valvular abnormality, their incidence is 8- to 10-fold increased
mong those who have a BAV.2,3,6 – 8 The burden of this complication falls disp
ortionately on the young, with a quarter of patients under the age of 40 years
resenting with dissection found to have a bicuspid valve.9
Despite the clinical effect of this condition, little is known of its cause. In the past
ecade, however, a great deal of progress has been made in understanding cardiac
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Dalve development and the role of signaling pathways, such
s vascular endothelial growth factor, nuclear factor of
ctivated T-cells calcineurin-dependent 1 (NFATC1),
otch gene homolog 1 (Notch), Wnt oncogene analog
Wnt)/ catenin, bone morphogenetic protein (BMP)/trans-
orming growth factor, beta (TGF-), epidermal growth
actor receptor related (ErbB), and neurofibromin 1 (NF1)/
as homolog gene family (Ras), that regulate endothelial
roliferation and differentiation in developing and postnatal
eart valves.10 A potential role for such pathways in 
athogenesis of BAV disease has been suggested by exper-
ments using gene knockout techniques in which heterozy-
ous ablation of NKX2-5 results in an 8-fold increase in the
revalence of stenotic BAVs in mice.11 Mounting evidence,
ncluding familial clustering of BAV2,12 and the association
f BAV with a variety of cardiac malformations in human
ubjects,13,14 supports a genetic cause of the disea
mong the candidates for such a gene, NKX2-5 is appealing
iven its important role in cardiac development in many
rganisms, including the frog, chick, mouse, and hu-
an.15–17 Nkx2-5 is also known to modulate the extrac-
ular matrix of the aorta during embryonic developmen18
n intriguing observation given the frequency with which
ortic abnormalities accompany BAV.
Given these observations, we hypothesized that muta-
ions in NKX2-5 will be associated with BAV in human
ubjects. Furthermore, because somatic NKX2-5 mutations
ave been recently demonstrated to be associated with con-
enital cardiac abnormalities,19 we tested our hypothesis b
creening both germline and somatic DNA.
ethods
atients and Sample Collection
amples of germline DNA derived from peripheral blood leuko-
ytes and somatic DNA from the ascending aorta were taken from
he Mayo Clinic Cardiovascular Surgery Aortic Aneurysm Tissue
ank. This resource has been built prospectively since March 2003
ith Mayo Clinic Institutional Review Board approval. Prospec-
ive study patients provide written consent for sample collection,
torage, and future confidential analyses as per protocol. Patients
re enrolled based on convenience of sample collection from
mong the total pool of patients undergoing ascending aortic
urgery. Because the principle interest of the laboratory is ascend-
ng aortic aneurysmal disease, patients in whom availability of
iscarded aortic tissue samples are anticipated are approached for
articipation. Both blood samples and aortic tissue (aneurysmal
Abbreviations and Acronyms
BAV bicuspid aortic valve
PCR  polymerase chain reaction
UTR  untranslated regionscending aorta and aortic root) were obtained from 22 patients d
302 The Journal of Thoracic and Cardiovascular Surgery ● Junndergoing ascending aortic replacement for aneurysmal disease.
ineteen of these patients had congenital BAV, and 3 patients had
rileaflet aortic valves. As shown in Table 1, the functional p
gy of the valve itself was variable. None had associated congen-
tal cardiac anomalies. Tissue samples were snap-frozen in liquid
itrogen and stored at 80°C until DNA was extracted.
olymerase Chain Reaction and DNA Sequencing
enomic DNA was isolated from peripheral blood of the patients
y using the standard method of the QIAamp DNA blood maxi kit,
ccording to the manufacturer’s protocol (QIAGEN, Almeda,
alif). Genomic DNA from the aorta was extracted with the
izard DNA extraction kit, according to the manufacturer’s pro-
ocol (Promega, Madison, Wis). The quality and quantity of iso-
ated DNA were checked on 1% agarose gel and with a
pectrophotometer.
The entire NKX2-5 coding sequence, including intron-exon
oundaries (Figure 1), was screened for mutation by mean
nitial polymerase chain reaction (PCR), followed by DNA se-
uencing. Briefly, PCR was performed in 25 L total volume
ontaining 100 ng of genomic DNA; 200 mol/L each of deoxya-
enosine triphosphate, deoxycytidine triphosphate, deox-
guanosine triphosphate, and deoxythymidine triphosphate; 0.05
nits of Taq DNA polymerase (Invitrogen, Carlsbad, Calif); 1.5
mol/L MgCl2 in 1 PCR buffer; and 2 mol/L of each primer.
rimer sequences covering both exons and intron-exon boundaries
Figure 1) of the NKX2-5 gene are as follows: 1AF, CGGCA
ATGCAGGGAAG; 1AR, AGGGTCCTTGGCTGGGTCGG
PCR size 404 bp); 1BF, CCTAAACCTGGAACAGCAGC; 1BR,
CCTGGCCCTGAGTTTCTTG (355 bp); 2AF, GCGCTCCG-
AGGTCAAGC; 2AR, TAGGGATTGAGGCCCACG (472 bp);
BF, GTTCCAGAACCGGCGCTACAAGTG; and 2BR,
CGCGTGGGACAGAAAAAGTTCCT (573 bp).
The amplification was carried out with a hot predenaturation
tart for 3 minutes at 94°C and subsequently with 35 cycles of
igure 1. Selection of primers covering entire exon-intron bound-
ries of the NKX2-5 gene. Details of the primers’ sequences (1AF,
AR, 1BF, 1BR, 2AF, 2AR, 2BF, and 2BR) and the PCR product sizes
re given in the text. UTR, Untranslated region.
able 1. Characteristics of patients
Patients AscAA AscAA  AS AscAA  AR
AV 6 10 3
AV 1 1 1
scAA, Ascending aortic aneurysms; AS, aortic stenosis; AR, aortic re-
urgitation; BAV, bicuspid aortic valve; TAV, tricuspid aortic valve.enaturation for 30 seconds at 94°C, annealing for 30 seconds at
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D2°C to 65°C (different primer sets need different annealing tem-
erature for PCR amplification), and extension for 30 seconds at
2°C. The PCR products were electrophoresed on 1% agarose gel.
he gel-isolated PCR products were analyzed by using double-
trand cycle sequencing with the BigDye Terminator v3.1 kit and
BI 3100 Genetic analyzer (Applied Biosystems, Foster City,
alif). Sequences were analyzed with SeqMan (DNASTAR, Mad-
son, Wis) and Chroma software (Version 1.45; Griffith Univer-
ity, Southport, Australia). Both sense and antisense strands of the
CR products were sequenced, and NM004387 from Genbank was
sed as a reference control sequence.
esults
irect sequencing of germline DNA derived from periph-
ral blood leukocytes did not reveal any alteration in the
rotein-coding regions. A known polymorphic alteration
T1212G) in the 3= untranslated region (UTR) adjacent to
xon 2 was identified in 4 patients with BAV and 2 control
ubjects (Table 2). There was no correlation between 
NA sequence variation and the phenotype/functional pa-
hology of the valve.
Sequence analysis of NKX2-5 fragments generated from
NA extracted from the excised aorta of the above individ-
als was performed to determine the presence of somatic
utations in the conotruncal tissues. A change from an A to
residue at position 239 (per Genebank reference sequence
M004387) was identified in 1 patient with BAV and 1
ontrol subject. This 239 A¡G transition causes a synon-
mous amino acid alteration of Glu21Glu, as reported ear-
ier.19 This alteration was not present in the correspond
ndividual’s germline DNA. A polymorphism (T1212G) in
he 3=-UTR adjacent to exon 2 was identified in aortic DNA
mong 6 patients with BAV and 1 control subject. Only 2 of
he 6 patients with BAV exhibited the same polymorphism
n their germline DNA. The control subject with this poly-
orphism exhibited the same in germline DNA. Con-
ersely, 2 of the patients with BAV and 1 control subject
xhibited this polymorphism in DNA derived from periph-
ral blood leukocytes but not in that derived from the
scending aorta (Table 2).
iscussion
he results of this study demonstrate that among the 19
ndividuals with BAV and aneurysm tested, polymor-
able 2. Detection of sequence variation in NKX2-5
Source Nucleotide change Location
BL DNA 1212 T¡G Exon 2, 3=-UT
ortic DNA 239 A¡G Exon 1 (21 Glu
ortic DNA 1212 T¡G Exon 2, 3=-UT
AV, Bicuspid aortic valve; TAV, tricuspid aortic valve; PBL, peripheral blhism in the coding region of NKX2-5 is not responsible t
The Journal of Thoracicor the valvular malformation. Germline DNA extracted
rom peripheral blood leukocytes demonstrated no abnor-
ality in the coding regions, and the only polymorphism
dentified in the 3=-UTR was present in both patients with
AV and control subjects. Somatic DNA extracted from
issue of conotruncal origin (ascending aorta) demon-
trated this same polymorphism in the 3=-UTR in 6 study
atients and 1 control subject. Furthermore, consonance
etween germline and somatic sequences was poor. A
ingle nucleotide polymorphism in somatic DNA in the
oding region was identified in 2 individuals; however,
his synonymous amino acid change (it signaled no
hange in protein sequence) was present both in 1 patient
ith BAV and a control subject with a trileaflet valve.
hese polymorphisms have been previously reported in
atients with complex congenital heart disease, including
diopathic atrioventricular block,19 as well as atrial sept
efect and tetralogy of Fallot. They have also been iden-
ified among individuals without apparent cardiac
isease.19
The limitations of this study must be recognized. The
trong association of BAV with NKX2-5 mutation in mice
ade this an important candidate gene in our series. A
egative study result with our small population size cannot
ule out mutation in NKX2-5 as a possible cause of a minor
ercentage of cases of BAV. Also, our selection bias in
avor of BAV associated with aneurysmal disease might
ave inadvertently reduced our chances of identifying an
ssociation if, for example, the phenotype in human subjects
ssociated with such a mutation were to be isolated BAV.
f note, however, our study sample did include patients
ith the full spectrum of functional pathology. It is also
ossible that a somatic mutation exists in the valve tissue
ut not in the associated ascending aorta. This is, in our
iew, unlikely because these structures are developmen-
ally derived from a common cell population.
The events involved in the developmental process of the
scending aorta, including BAV formation, are poorly un-
erstood. It has been suggested that abnormalities in com-
onents of the extracellular matrix or aberrant vascular
atrix remodeling might contribute to abnormal valvulo-
enesis and a structurally weakened aortic root.14 The aortic
alve leaflets originate from mesenchymal outgrowths
No. of patients with BAV
(patient ID no.)
No. of patients with TAV
(patient ID no.)
4 (3, 5, 16, 21) 2 (7, 14)
1 (11) 1 (13)
6 (3, 5, 8, 9, 12, 22) 1 (7)
ukocytes; UTR, untranslated region.R
)
Rermed cardiac cushions arising from regional thickenings
and Cardiovascular Surgery ● Volume 131, Number 6 1303
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Df the cardiac jelly, the extracellular matrix that resides
etween the myocardium and endocardium of the primitive
eart tube.20 Further contribution of neural crest cells in 
evelopment of the ascending aorta, including the aortic
alve, is recognized.21 Because BAV is often accompani
y congenital abnormalities of the aorta, the process under-
ying BAV formation might involve more than just the
nappropriate fusion of adjacent leaflets and might represent
 genetic disease that affects the entire aortic root,14 as well
s the wall.22
A homeodomain transcription factor, NKX2-5 in the human
ubject maps to chromosome 5q34 and consists of 2 exons
oding a protein of 324 amino acids. Previous studies have
hown 5 other NKX2-5 mutations conferring a range of cardiac
bnormalities, including severe arterioventricular conduction
locks, ventricular septal defect, left ventricular hypertrophy,
etralogy of Fallot, double-outlet right ventricle, subvalvular
ortic stenosis, and tricuspid valve abnormality.23–28 The fre-
uency of these mutations in the general population is un-
nown. In knockout mice homozygous deletion of Nkx2-5 is
ethal; however, heterozygous mutation of Nkx2-5 results in
mpaired cardiac development, thus demonstrating an essential
ole for this gene in normal heart morphogenesis and func-
ion.23–26 Previous work has demonstrated that heterozygo
utation in the Nkx2-5 gene increased the frequency of BAV
n the mice from 1.4% to 11%.11 The presence of BAVs 
ice was strictly dependent on genetic background, being
ound only in the C57B1/6 strain, suggesting an influence of
nother genetic modifier.
Given the frequency of BAV in the population and the
bserved phenotypic variability, including both valve mor-
hology and the presence or absence of associated aortic an-
urysmal disease, as well as the association of BAV with a
ariety of complex congenital syndromes2,19,22,28 in human
ubjects, it is likely that more than one genetic abnormality
ould lead to this congenital malformation. Other candidate
enes have been proposed. An association of mutations in the
OTCH1 gene with a complex of cardiac anomalies, including
entricular septal defect, hypoplastic left ventricle, mitral atre-
ia, and double-outlet right ventricle, as well as BAV and
alvular calcification among many affected family members,
as recently been reported.29 Of note, ascending aortic ane-
ysm was not among the phenotypic characteristics described
n these families. Alterations in endothelial nitric oxide syn-
hase levels have also been associated with BAV formation in
ice,30 supporting genetic heterogeneity in the cause of B
n the murine system. Abnormalities in NKX2-5 remain a
elevant possibility as well in some cases. Although we did not
etect any mutation in the protein coding sequence of NKX2-5
rom patients with BAV, it is possible that a relevant mutation
ould be present elsewhere in the NKX2-5 gene, such as a
romoter, an intron, or the 3=-UTR. Finally, there might be an
ssociation of BAV with NKX2-5–related signaling cascade or
304 The Journal of Thoracic and Cardiovascular Surgery ● Junetwork either within an upstream regulator or a downstream
arget. Alternatively, the absence of NKX2-5 involvement in
uman BAV might reflect a different developmental pattern of
scending aorta in mice and human subjects.
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